Oncology PracticeShort sleep duration increases risk of death in patients with metastatic colorectal cancerFebruary 18, 2016GastroenterologyPatient & Survivor CareGastrointestinal Cancer
Oncology PracticeWide disparity in radiology reads without RECISTFebruary 16, 2016GastroenterologyGastrointestinal Cancer
Hematology NewsDo we give too much iron?February 10, 2016GastroenterologyAnemiaGastrointestinal Cancer
Oncology PracticeEarly mortality predicted by age and poor performance status in patients with colon cancerFebruary 8, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeMAVERICC: Search for predictive biomarkers in first-line colorectal cancer trial goes onFebruary 4, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeOffice visits still common before colonoscopyFebruary 2, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeRT for rectal cancer may reduce risk of some other cancersFebruary 1, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeSurvival of pancreatic cancer is better when adjuvant therapy is given in high-volume centersJanuary 31, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticePD-1 blockade impresses in mismatch repair–deficient GI cancersJanuary 29, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeImmune checkpoint inhibitors have antitumor activity in gastric, esophageal cancersJanuary 28, 2016GastroenterologyRenal Cell CarcinomaGastrointestinal Cancer
Oncology PracticeHigh participation, steady sensitivity for CRC with annual FIT screeningJanuary 25, 2016GastroenterologyPreventive CareGI OncologyGastrointestinal Cancer
Oncology PracticeAdjuvant oxaliplatin reduces colon cancer recurrence, deathsJanuary 25, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeNew neoadjuvant regimen for locally advanced rectal cancer is efficaciousJanuary 21, 2016GastroenterologyGastrointestinal Cancer
Oncology PracticeBiomarker may ID high-risk colon cancersJanuary 20, 2016GastroenterologyGI OncologyGastrointestinal Cancer
Oncology PracticeEverolimus is effective across diverse patients with GI neuroendocrine tumorsJanuary 20, 2016GastroenterologyGI OncologyGastrointestinal Cancer
